Standard Biotools (LAB) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.99% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.52% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.25% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 32.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.42% |
| Dec 31, 2025 | 13.66% |
| Sep 30, 2025 | 28.34% |
| Jun 30, 2025 | 28.15% |
| Mar 31, 2025 | 70.44% |
| Dec 31, 2024 | 78.93% |
| Sep 30, 2024 | 91.19% |
| Jun 30, 2024 | 104.12% |
| Mar 31, 2024 | 78.43% |
| Dec 31, 2023 | -8.94% |
| Sep 30, 2023 | 3.12% |
| Jun 30, 2023 | 48.11% |
| Mar 31, 2023 | 46.95% |
| Dec 31, 2022 | 51.37% |
| Sep 30, 2022 | 29.85% |
| Jun 30, 2022 | 42.37% |
| Mar 31, 2022 | -22.12% |
| Dec 31, 2021 | -32.40% |
| Sep 30, 2021 | -5.41% |
| Jun 30, 2021 | -6.84% |
| Mar 31, 2021 | 6.54% |
| Dec 31, 2020 | 6.20% |
| Sep 30, 2020 | 6.38% |
| Jun 30, 2020 | 3.61% |
| Mar 31, 2020 | -6.48% |
| Dec 31, 2019 | -12.18% |
| Sep 30, 2019 | -4.70% |
| Jun 30, 2019 | -10.06% |
| Mar 31, 2019 | 15.27% |
| Dec 31, 2018 | 48.53% |
| Sep 30, 2018 | 7.53% |
| Jun 30, 2018 | 18.41% |
| Mar 31, 2018 | 4.31% |
| Dec 31, 2017 | 19.86% |
| Sep 30, 2017 | 25.35% |
| Jun 30, 2017 | -3.22% |
| Mar 31, 2017 | -24.14% |
| Dec 31, 2016 | -0.20% |
| Sep 30, 2016 | 17.14% |
| Jun 30, 2016 | 3.59% |
| Mar 31, 2016 | -11.50% |
| Dec 31, 2015 | -20.82% |
| Sep 30, 2015 | -24.14% |
| Jun 30, 2015 | 34.07% |
| Mar 31, 2015 | 63.28% |
| Dec 31, 2014 | 35.49% |
| Sep 30, 2014 | 37.58% |
| Jun 30, 2014 | 62.77% |
| Mar 31, 2014 | 21.86% |
| Dec 31, 2013 | 83.33% |
| Sep 30, 2013 | 58.13% |
| Jun 30, 2013 | 58.76% |